Form 4: H.B. Fuller Co. Executive Campe Reports Stock and Options Activity
SEC Form 4 Filing
Heather Campe, Sr. VP of International Growth at H.B. Fuller Co., reports transactions involving common stock, phantom units, and stock options.
Summary
- Heather Campe, a Senior Vice President at H.B. Fuller Co., filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- The report includes transactions related to common stock, phantom units, employee stock options, and restricted stock units.
- As of January 31, 2025, Campe directly owns 22,316.23 shares of common stock.
- She also holds various employee stock options with exercise prices ranging from $51.89 to $77.72 and expiration dates between 2028 and 2035, totaling 74,559 options.
- Campe also holds 4,283.53 phantom units and various restricted stock units that vest in annual installments.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions, with no clear positive or negative implications for the company's outlook.
Positives
- The reporting person's continued holding of a significant number of shares and options indicates confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules of the options and restricted stock units suggest a continued relationship between the reporting person and the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of the options are typical for executive compensation plans.
- Comparing the size of the holdings and option grants to those of executives at peer companies (e.g., 3M, Sherwin-Williams) would provide further context.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The information may influence investor sentiment, although the impact is likely to be minimal given the routine nature of the filing.
Key Dates
| Date | Description |
|---|---|
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57, expiring on 01/25/2028. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89, expiring on 01/27/2031. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94, expiring on 01/24/2032. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17, expiring on 01/24/2033, and the start date for vesting of restricted stock units expiring on 01/24/2026. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72, expiring on 01/26/2034, and the start date for vesting of restricted stock units expiring on 01/26/2027. |
| 01/27/2026 | Date of employee stock option grant with an exercise price of $64.28, expiring on 01/27/2035, and the start date for vesting of restricted stock units expiring on 01/27/2028. |
| 01/31/2025 | Date of the earliest transaction reported and acquisition of phantom units. |
| 02/03/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.